Abstract

Thyroid cancer is one of the most common endocrine tumors. Medical imaging examinations play a major role in diagnosing thyroid carcinoma and evaluating its therapeutic response. Recently, molecular imaging, as an emerging discipline, has made significant progress in qualitatively and quantitatively demonstrating the specific molecular alteration of thyroid cancer in cellular and molecular levels in vivo. This article is a summary of the advances on the molecular imaging diagnosis and the targeted therapy of thyroid cancer at home and abroad. Key words: Thyroid neoplasms; Molecular diaghostic techniques; Tomography, emission-computed; Radiotherapy

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.